AGP Executive Report
Last update: 2 hours agoShamonda Virus: Health authorities are investigating the first recorded human infection, in an immunocompromised older man in France who died after developing encephalitis. It is not yet clear whether the virus contributed to his death or how he became infected; experts caution that one case does not establish a wider risk. Cancer Care: Anktiva, a bladder-cancer treatment, has been given to its first patients in Europe, in Germany and Austria. Its conditional EU approval also covers Liechtenstein. Medicine Safety: The European Medicines Agency is reviewing Deanxit, used for depression and anxiety, after reports of movement disorders and problems with memory and thinking, sometimes persisting after treatment stopped. Health Cover: Genki has expanded its international health insurance, underwritten by Liechtenstein-based Squarelife, with cover options from one month and added preventive and dental care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
